Delinia, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Delinia, Inc..The latest application filed is for "molecules that selectively activate regulatory t cells for the treatment of autoimmune diseases".

Company Profile

24.16.35

Delinia, Inc. - Emeryville CA
DELINIA, INC. - Cambridge MA US
Delinia, Inc. - Berkeley CA US
DELINIA, INC. -

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Molecules That Selectively Activate Regulatory T Cells For The Treatment Of Autoimmune Diseases App 20220112260 - Greve; Jeffrey	2022-04-14
Multivalent Regulatory T Cell Modulators App 20210403579 - Kim; Jungmin ; et al.	2021-12-30
Il-2 Variants For The Treatment Of Autoimmune Diseases App 20210308222 - Greve; Jeffrey	2021-10-07
IL-2 variants for the treatment of psoriasis Grant 11,077,172 - Greve August 3, 2	2021-08-03
Multivalent regulatory T cell modulators Grant 11,059,877 - Greve , et al. July 13, 2	2021-07-13
Molecules That Selectively Activate Regulatory T Cells For The Treatment Of Autoimmune Diseases App 20210070828 - Greve; Jeffrey	2021-03-11
Molecules That Selectively Activate Regulatory T Cells For The Treatment Of Autoimmune Diseases App 20210047382 - Greve; Jeffrey	2021-02-18
Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseases Grant 10,875,901 - Greve December 29, 2	2020-12-29
Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseases Grant 10,774,126 - Greve September 15, 2	2020-09-15
Nucleic acid encoding human IL-2 variant Grant 10,766,938 - Greve Sep	2020-09-08
Molecules That Selectively Activate Regulatory T Cells For The Treatment Of Autoimmune Diseases App 20200115429 - Greve; Jeffrey	2020-04-16
Multivalent Regulatory T Cell Modulators App 20200031897 - Greve; Jeffrey ; et al.	2020-01-30
Molecules That Selectively Activate Regulatory T Cells For The Treatment Of Autoimmune Diseases App 20190375812 - Greve; Jeffrey	2019-12-12
Multivalent regulatory T cell modulators Grant 10,472,405 - Greve , et al. Nov	2019-11-12
Molecules That Selectively Activate Regulatory T Cells For The Treatment Of Autoimmune Diseases App 20190202882 - Greve; Jeffrey	2019-07-04
Molecules That Selectively Activate Regulatory T Cells For The Treatment Of Autoimmune Diseases App 20190202881 - Greve; Jeffrey	2019-07-04
Molecules That Selectively Activate Regulatory T Cells For The Treatment Of Autoimmune Diseases App 20190153058 - Greve; Jeffrey	2019-05-23
Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseases Grant 10,294,287 - Greve	2019-05-21
Modified IL-2 variants that selectively activate regulatory T cells Grant 10,035,836 - Greve July 31, 2	2018-07-31
Multivalent Regulatory T Cell Modulators App 20180162919 - Greve; Jeffrey ; et al.	2018-06-14
IL-2 Variants for the Treatment of Autoimmune Diseases App 20180125941 - Greve; Jeffrey	2018-05-10
Molecules That Selectively Activate Regulatory T Cells For The Treatment Of Autoimmune Diseases App 20180037624 - Greve; Jeffrey	2018-02-08
Molecules That Selectively Activate Regulatory T Cells For The Treatment Of Autoimmune Diseases App 20170327555 - Greve; Jeffrey	2017-11-16
Molecules That Selectively Activate Regulatory T Cells For The Treatment Of Autoimmune Diseases App 20170204154 - Greve; Jeffrey	2017-07-20
Molecules That Selectively Activate Regulatory T Cells For The Treatment Of Autoimmune Diseases App 20170051029 - GREVE; Jeffrey	2017-02-23
Molecules That Selectively Activate Regulatory T Cells For The Treatment Of Autoimmune Diseases App 20170037102 - GREVE; Jeffrey	2017-02-09

Company Registrations

NCAGE Code	78JR6	DELINIA, INC!DBA DELINIA
CAGE Code	78JR6	DELINIA, INC DELINIA
DUNS	079603368	Delinia, Inc

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.